You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 8, August 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Liver/ Biliary Tract/ Pancreatic Diseases
 •Pediatric Neurology
 •Pediatrics
 •Pediatrics, Other
 •Alert me on articles by topic

Hepatocerebral Mitochondrial DNA Depletion Syndrome Caused by Deoxyguanosine Kinase (DGUOK) Mutations

Peter Freisinger, MD; Nancy Fütterer, MD; Erwin Lankes, MD; Klaus Gempel, MD; Thomas M. Berger, MD; Johannes Spalinger, MD; Alexandra Hoerbe, MD; Claudia Schwantes, MD; Martin Lindner, MD; René Santer, MD; Martin Burdelski, MD; Hansjörg Schaefer, MD; Bernhard Setzer, PhD; Ulrich A. Walker, MD; Rita Horváth, MD

Arch Neurol. 2006;63:1129-1134.

Background  Autosomal recessive mutations in deoxyguanosine kinase (DGUOK) have been identified in the hepatocerebral form of mitochondrial DNA (mtDNA) depletion syndrome.

Objectives  To describe the clinical spectrum of DGUOK-related mtDNA depletion syndrome in 6 children and to summarize the literature.

Results  We identified pathogenic mutations in DGUOK in 6 children with the hepatocerebral form of mtDNA depletion syndrome. We describe the clinical, neuroradiologic, histologic, and genetic features in these children. All children showed severe hepatopathy, while involvement of other organs (skeletal muscle and brain) was variable. We identified 5 novel mutations (1 of them in 2 children) and 2 previously described mutations. Three different mutations affected the initial methionine, suggesting a mutational hot spot. One of our patients underwent liver transplantation; pathologic findings revealed (in addition to diffuse hepatopathy) a hepatocellular carcinoma, implying a possible link between mtDNA depletion syndrome and tumorigenesis.

Conclusion  We studied 12 children with infantile hepatoencephalopathies and mtDNA depletion syndrome and found pathogenic DGUOK mutations in 6, suggesting that this gene defect is a frequent but not an exclusive cause of the hepatic form of mtDNA depletion syndrome.


Author Affiliations: Metabolic Disease Center Munich-Schwabing (Drs Freisinger, Fütterer, Lankes, Gempel, and Horváth); Institutes of Clinical Chemistry, Molecular Diagnostics, and Mitochondrial Genetics, Academic Hospital Schwabing (Drs Gempel and Horváth); and Children's Hospital and Institute of Medical Genetics, Technical University Munich (Drs Freisinger, Fütterer and Lankes); Munich; Pediatric Clinic, Hospital of the City of Cologne, Cologne (Drs Hoerbe and Schwantes); Pediatric Clinic, University of Heidelberg, Heidelberg (Dr Lindner); Institute of Pathology, University of Hamburg, Hamburg (Drs Santer, Burdelski, and Schaefer); and Department of Rheumatology, Freiburg University Hospital, Freiburg (Drs Setzer and Walker), Germany; and Pediatric Clinic Kinderspital Luzern, Luzern, Switzerland (Drs Berger and Spalinger).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Human UMP-CMP Kinase 2, a Novel Nucleoside Monophosphate Kinase Localized in Mitochondria
Xu et al.
J. Biol. Chem. 2008;283:1563-1571.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.